Literature DB >> 29519867

Prognostic impact of the absence of biallelic deletion at the TRG locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial.

Nadine Farah1, Amy A Kirkwood2, Sunniyat Rahman1, Theresa Leon1, Sarah Jenkinson1, Rosemary E Gale1, Katharine Patrick3, Jeremy Hancock4, Sujith Samarasinghe5, David C Linch1, Anthony V Moorman6, Nicholas Goulden5, Ajay Vora3,5, Marc R Mansour7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29519867      PMCID： PMC6029550          DOI： 10.3324/haematol.2017.185801

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Suzanne E Dahlberg; Donna S Neuberg; Jianhua Zhang; Ruta Grebliunaite; Takaomi Sanda; Alexei Protopopov; Valeria Tosello; Jeffery Kutok; Richard S Larson; Michael J Borowitz; Mignon L Loh; Adolfo A Ferrando; Stuart S Winter; Charles G Mullighan; Lewis B Silverman; Lynda Chin; Stephen P Hunger; Stephen E Sallan; A Thomas Look
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.

Authors:  Valentino Conter; Maria Grazia Valsecchi; Barbara Buldini; Rosanna Parasole; Franco Locatelli; Antonella Colombini; Carmelo Rizzari; Maria Caterina Putti; Elena Barisone; Luca Lo Nigro; Nicola Santoro; Ottavio Ziino; Andrea Pession; Anna Maria Testi; Concetta Micalizzi; Fiorina Casale; Paolo Pierani; Simone Cesaro; Monica Cellini; Daniela Silvestri; Giovanni Cazzaniga; Andrea Biondi; Giuseppe Basso
Journal:  Lancet Haematol       Date:  2016-01-26       Impact factor: 18.959

3.  Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.

Authors:  Jonathan Bond; Carlos Graux; Ludovic Lhermitte; Diane Lara; Thomas Cluzeau; Thibaut Leguay; Agata Cieslak; Amélie Trinquand; Cedric Pastoret; Mohamed Belhocine; Salvatore Spicuglia; Véronique Lheritier; Stéphane Leprêtre; Xavier Thomas; Françoise Huguet; Norbert Ifrah; Hervé Dombret; Elizabeth Macintyre; Nicolas Boissel; Vahid Asnafi
Journal:  J Clin Oncol       Date:  2017-06-12       Impact factor: 44.544

4.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

5.  Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.

Authors:  Nitin Jain; Audrey V Lamb; Susan O'Brien; Farhad Ravandi; Marina Konopleva; Elias Jabbour; Zhuang Zuo; Jeffrey Jorgensen; Pei Lin; Sherry Pierce; Deborah Thomas; Michael Rytting; Gautam Borthakur; Tapan Kadia; Jorge Cortes; Hagop M Kantarjian; Joseph D Khoury
Journal:  Blood       Date:  2016-01-08       Impact factor: 22.113

6.  Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.

Authors:  S Jenkinson; K Koo; M R Mansour; N Goulden; A Vora; C Mitchell; R Wade; S Richards; J Hancock; A V Moorman; D C Linch; R E Gale
Journal:  Leukemia       Date:  2012-07-03       Impact factor: 11.528

7.  Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia.

Authors:  David O'Connor; Anthony V Moorman; Rachel Wade; Jeremy Hancock; Ronald M R Tan; Jack Bartram; John Moppett; Claire Schwab; Katharine Patrick; Christine J Harrison; Rachael Hough; Nick Goulden; Ajay Vora; Sujith Samarasinghe
Journal:  J Clin Oncol       Date:  2017-01-03       Impact factor: 44.544

8.  New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling.

Authors:  Willem A Dik; Karin Pike-Overzet; Floor Weerkamp; Dick de Ridder; Edwin F E de Haas; Miranda R M Baert; Peter van der Spek; Esther E L Koster; Marcel J T Reinders; Jacques J M van Dongen; Anton W Langerak; Frank J T Staal
Journal:  J Exp Med       Date:  2005-05-31       Impact factor: 14.307

9.  Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.

Authors:  Katharine Patrick; Rachel Wade; Nick Goulden; Chris Mitchell; Anthony V Moorman; Clare Rowntree; Sarah Jenkinson; Rachael Hough; Ajay Vora
Journal:  Br J Haematol       Date:  2014-04-08       Impact factor: 6.998

10.  Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.

Authors:  S Jenkinson; A A Kirkwood; N Goulden; A Vora; D C Linch; R E Gale
Journal:  Leukemia       Date:  2015-07-29       Impact factor: 11.528
View more
  1 in total

1.  MEF2C expression, but not absence of bi-allelic deletion of TCR gamma chains (ABD), is a predictor of patient outcome in Indian T-acute lymphoblastic leukemia.

Authors:  Jay Singh; Rajive Kumar; Deepak Verma; Nishi Rajput; Jayanth Kumar Palanichamy; Gunjan Sharma; Sameer Bakhshi; Atul Sharma; Deepam Pushpam; Rachna Seth; Amar Ranjan; Pranay Tanwar; Archna Singh; Mohit Arora; Sarita Kumari; Anita Chopra
Journal:  Am J Blood Res       Date:  2020-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.